These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34811884)

  • 1. Alginate and its Two Components Acted Differently Against Dopaminergic Neuronal Loss in Parkinson's Disease Mice Model.
    Du ZR; Wang X; Cao X; Liu X; Zhou SN; Zhang H; Yang RL; Wong KH; Tang QJ; Dong XL
    Mol Nutr Food Res; 2022 Jan; 66(2):e2100739. PubMed ID: 34811884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
    Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
    Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson's disease.
    Liu X; Du ZR; Wang X; Sun XR; Zhao Q; Zhao F; Wong WT; Wong KH; Dong XL
    Food Res Int; 2022 May; 155():111067. PubMed ID: 35400445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low and high doses of oral maslinic acid protect against Parkinson's disease via distinct gut microbiota-related mechanisms.
    Cao X; Du ZR; Liu X; Wang X; Li C; Zhou SN; Liu JR; Xu PY; Ye JL; Zhao Q; Zhao F; Wong KH; Dong XL
    Biomed Pharmacother; 2023 Sep; 165():115100. PubMed ID: 37418977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salusin-β mediate neuroprotective effects for Parkinson's disease.
    Chang Y; Yoo J; Kim H; Park HJ; Jeon S; Kim J
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1428-1433. PubMed ID: 30017195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.
    Wu L; Du ZR; Xu AL; Yan Z; Xiao HH; Wong MS; Yao XS; Chen WF
    Biomed Pharmacother; 2017 Jul; 91():656-663. PubMed ID: 28494419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
    Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
    Kikuoka R; Miyazaki I; Kubota N; Maeda M; Kagawa D; Moriyama M; Sato A; Murakami S; Kitamura Y; Sendo T; Asanuma M
    Sci Rep; 2020 Nov; 10(1):20698. PubMed ID: 33244123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson's disease.
    Ben Youssef S; Brisson G; Doucet-Beaupré H; Castonguay AM; Gora C; Amri M; Lévesque M
    Nutr Neurosci; 2021 Mar; 24(3):197-211. PubMed ID: 31131731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.
    Chetia Phukan B; Dutta A; Deb S; Saikia R; Mazumder MK; Paul R; Bhattacharya P; Sandhir R; Borah A
    Exp Brain Res; 2022 Jan; 240(1):113-122. PubMed ID: 34633467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
    Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
    Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.